Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | LIMK1 | P53667 | 5/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.34 |
| ▸ | F9 | P00740 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10133864 | 0.93 | BCL2L1 (0.38) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL19010386 | 0.92 | LIMK1 (0.41) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL25811188 | 0.89 | ESR1 (0.37) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL21423194 | 0.86 | ROCK1 (0.43) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL17993365 | 0.86 | MAP4K4 (0.44) | ALDH1A1HPGDMAPTRAB9ACYP1A2 | |
| SCHEMBL10133866 | 0.85 | BCL2L1 (0.41) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL21215402 | 0.85 | LIMK1 (0.34) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL25946299 | 0.85 | PIM3 (0.43) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL25620648 | 0.85 | PIM3 (0.43) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL23018806 | 0.85 | PIM3 (0.43) | ALDH1A1HPGDMAPTRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10944061-B2 | Organic electroluminescent element and compound | UDC IRELAND LIMITED (IE) | 2021-03-09 | — | — | US | disclosed |
| US-20130270530-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND | UDC IRELAND LIMITED (IE) | 2013-10-17 | — | — | US | disclosed |
| US-20130270530-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND | UDC IRELAND LIMITED (IE) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10944061-B2 | Organic electroluminescent element and compound | POU2F2, DDT, LEF1 | ALDH1A1 1094/4885HPGD 3918/4885MAPT 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.